Efficacy of serotonin type 3 receptor antagonist ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome with inactive Crohn's disease, a pilot trial

Nakamura K.; Tomita T.; Oshima T.; Fukui H.; Watari J.; Miwa H.

首页> 外文期刊>Neurogastroenterology and motility >Efficacy of serotonin type 3 receptor antagonist ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome with inactive Crohn's disease, a pilot trial

【24h】

Efficacy of serotonin type 3 receptor antagonist ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome with inactive Crohn's disease, a pilot trial

机译：血清素3型受体拮抗剂雷莫司琼治疗腹泻型肠易激综合症合并非活动性克罗恩病的疗效，一项先导试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Neurogastroenterology and motility》 |2014年第1期|共1页
作者
Nakamura K.; Tomita T.; Oshima T.; Fukui H.; Watari J.; Miwa H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of serotonin type 3 receptor antagonist ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome with inactive Crohn's disease, a pilot trial [J] . Nakamura K., Tomita T., Oshima T., Neurogastroenterology and motility . 2014,第Suppla1期

机译：血清素3型受体拮抗剂雷莫司琼治疗腹泻型肠易激综合症合并非活动性克罗恩病的疗效，一项先导试验
2. A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome. [J] . Matsueda K, Harasawa S, Hongo M, Digestion . 2008,第3a4期

机译：在患有腹泻为主的肠易激综合征的日本男性和女性患者中，新型3型血清素受体拮抗剂雷莫司琼的II期试验。
3. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. [J] . Matsueda K, Harasawa S, Hongo M, Scandinavian journal of gastroenterology. . 2008,第10期

机译：新型5-羟色胺3型受体拮抗剂雷莫司琼对腹泻型肠易激综合征的男性和女性患者的有效性的随机，双盲，安慰剂对照临床试验。
4. The Effects of Wumei Pill on Intestinal Flora and Neurotransmitters in Rats with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [C] . Xiaojie Ding, Xiling Sun, Xiaofei Yu, International Conference on Biotechnology and Bioengineering . 2019

机译：尿布丸对腹泻的肠道菌群和神经递质的影响（IBS-D）
5. Mindfulness-Based Stress Reduction for the treatment of irritable bowel syndrome symptoms: A randomized waitlist control trial. [D] . Zernicke, Kristin. 2009

机译：基于正念的压力减轻治疗肠易激综合症的症状：一项随机的候补对照试验。
6. Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome [O] . Toshimi Chiba, Kazunari Yamamoto, Shoko Sato, 2013

机译：雷莫司琼治疗腹泻型肠易激综合征的长期疗效和安全性
7. A Randomized Controlled Clinical Trial of the Serotonin Type 3 Receptor Antagonist Alosetron in Women With Diarrhea-Predominant Irritable Bowel Syndrome [O] . Michael Camilleri, William Y. Chey, Emeran A. Mayer, 2001

机译：随机对照临床试验的血清素3型受体拮抗剂Alosetron患有腹泻的妇女侵蚀性肠综合征

Efficacy of serotonin type 3 receptor antagonist ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome with inactive Crohn's disease, a pilot trial

著录项

引文网络

相似文献

相关主题

期刊订阅